Intervention Review

Terlipressin for hepatorenal syndrome

  1. Lise Lotte Gluud1,*,
  2. Kurt Christensen2,
  3. Erik Christensen3,
  4. Aleksander Krag4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 31 JAN 2012

DOI: 10.1002/14651858.CD005162.pub3

How to Cite

Gluud LL, Christensen K, Christensen E, Krag A. Terlipressin for hepatorenal syndrome. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD005162. DOI: 10.1002/14651858.CD005162.pub3.

Author Information

  1. 1

    Gentofte University Hospital, Department of Internal Medicine, Hellerup, Denmark

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

  3. 3

    Bispebjerg Hospital, Clinic of Internal Medicine I, Copenhagen, NV, Denmark

  4. 4

    Copenhagen University Hospital Hvidovre, Department of Gastroenterology 360, Hvidovre, Denmark

*Lise Lotte Gluud, Department of Internal Medicine, Gentofte University Hospital, Niels Andersensvej 65, Hellerup, 2900, Denmark.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 SEP 2012


  1. Current Version

    Terlipressin for hepatorenal syndrome

    Lise Lotte Gluud, Kurt Christensen, Erik Christensen and Aleksander Krag

    Version of Record online: 12 SEP 2012 | DOI: 10.1002/14651858.CD005162.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Terlipressin for hepatorenal syndrome

    Lise Lotte Gluud, Mette S Kjaer and Erik Christensen

    Version of Record online: 18 OCT 2006 | DOI: 10.1002/14651858.CD005162.pub2

  2. Version 1

    Terlipressin for hepatorenal syndrome

    LL Gluud, MS Kjaer, A Taastroem and E Christensen

    Version of Record online: 24 JAN 2005 | DOI: 10.1002/14651858.CD005162